Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

THEOCLEAR-200

THEOPHYLLINE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview THEOCLEAR-200 is listed in Drugs@FDA under application 085353 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET;ORAL - 200MG Sponsor CENT PHARMS Submission history Latest submission status date: 1980-08-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview THEOCLEAR-200 is listed in Drugs@FDA under application 085353 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET;ORAL - 200MG Sponsor CENT PHARMS Submission history Latest submission status date: 1980-08-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
THEOCLEAR-200 (THEOPHYLLINE) | Drug Monograph | MedicHelpline